Literature DB >> 27481849

Enhanced Requirement for TNFR2 in Graft Rejection Mediated by Low-Affinity Memory CD8+ T Cells during Heterologous Immunity.

Scott M Krummey1, Ching-Wen Chen1, Sara A Guasch1, Danya Liu1, Maylene Wagener1, Christian P Larsen1, Mandy L Ford2.   

Abstract

The affinity of a TCR binding to peptide:MHC profoundly impacts the phenotype and function of effector and memory cell differentiation. Little is known about the effect of low-affinity priming on memory cell generation and function, which is particularly important in heterologous immunity, when microbe-specific T cells cross-react with allogeneic Ag and mediate graft rejection. We found that low-affinity-primed memory CD8(+) T cells produced high levels of TNF ex vivo in response to heterologous rechallenge compared with high-affinity-primed memory T cells. Low-affinity secondary effectors significantly upregulated TNFR2 on the cell surface and contained a higher frequency of TNFR2(hi) proliferating cells. Low-affinity-primed secondary effectors concurrently downregulated TNF production. Importantly, blockade of TNFR2 attenuated graft rejection in low- but not high-affinity-primed animals. These data establish a functional connection between TNF signaling and TCR-priming affinity and have implications for the immunomodulation of pathogenic T cell responses during transplantation.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27481849      PMCID: PMC4992585          DOI: 10.4049/jimmunol.1502680

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  30 in total

1.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

Review 2.  TCR signaling requirements for activating T cells and for generating memory.

Authors:  Dietmar Zehn; Carolyn King; Michael J Bevan; Ed Palmer
Journal:  Cell Mol Life Sci       Date:  2012-04-19       Impact factor: 9.261

3.  Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.

Authors:  Scott M Krummey; Ryan J Martinez; Rakieb Andargachew; Danya Liu; Maylene Wagener; Jacob E Kohlmeier; Brian D Evavold; Christian P Larsen; Mandy L Ford
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

4.  The costimulatory molecule CD27 maintains clonally diverse CD8(+) T cell responses of low antigen affinity to protect against viral variants.

Authors:  Klaas P J M van Gisbergen; Paul L Klarenbeek; Natasja A M Kragten; Peter-Paul A Unger; Marieke B B Nieuwenhuis; Felix M Wensveen; Anja ten Brinke; Paul P Tak; Eric Eldering; Martijn A Nolte; Rene A W van Lier
Journal:  Immunity       Date:  2011-07-14       Impact factor: 31.745

5.  Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells.

Authors:  Xin Chen; Ryoko Hamano; Jeffrey J Subleski; Arthur A Hurwitz; O M Zack Howard; Joost J Oppenheim
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

6.  TNF-alpha is critical for antitumor but not antiviral T cell immunity in mice.

Authors:  Thomas Calzascia; Marc Pellegrini; Håkan Hall; Laurent Sabbagh; Nobuyuki Ono; Alisha R Elford; Tak W Mak; Pamela S Ohashi
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

7.  Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.

Authors:  Xin Chen; Jeffrey J Subleski; Heather Kopf; O M Zack Howard; Daniela N Männel; Joost J Oppenheim
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

Review 8.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

9.  Heterologous immunity provides a potent barrier to transplantation tolerance.

Authors:  Andrew B Adams; Matthew A Williams; Thomas R Jones; Nozomu Shirasugi; Megan M Durham; Susan M Kaech; E John Wherry; Thandi Onami; J Gibson Lanier; Kenneth E Kokko; Thomas C Pearson; Rafi Ahmed; Christian P Larsen
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Complete but curtailed T-cell response to very low-affinity antigen.

Authors:  Dietmar Zehn; Sarah Y Lee; Michael J Bevan
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  6 in total

Review 1.  Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans.

Authors:  James S Young; Christine McIntosh; Maria-Luisa Alegre; Anita S Chong
Journal:  Transplantation       Date:  2017-11       Impact factor: 4.939

Review 2.  Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders.

Authors:  Ling Chen; Zhu Shen
Journal:  Cell Mol Immunol       Date:  2019-10-08       Impact factor: 11.530

Review 3.  The Significance of Tumor Necrosis Factor Receptor Type II in CD8+ Regulatory T Cells and CD8+ Effector T Cells.

Authors:  Lin-Lin Ye; Xiao-Shan Wei; Min Zhang; Yi-Ran Niu; Qiong Zhou
Journal:  Front Immunol       Date:  2018-03-22       Impact factor: 7.561

Review 4.  Cheating the Hunger Games; Mechanisms Controlling Clonal Diversity of CD8 Effector and Memory Populations.

Authors:  Inga Kavazović; Bojan Polić; Felix M Wensveen
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 5.  Tissue-resident memory T cells in chronic liver diseases: Phenotype, development and function.

Authors:  Yikang Li; Zhengrui You; Ruqi Tang; Xiong Ma
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

Review 6.  Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.

Authors:  Huimin Zou; Ruixin Li; Hao Hu; Yuanjia Hu; Xin Chen
Journal:  Front Immunol       Date:  2018-03-26       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.